GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.290
-0.030 (-1.29%)
At close: Apr 29, 2026, 4:00 PM EDT
2.290
0.00 (0.00%)
After-hours: Apr 29, 2026, 4:47 PM EDT
GoodRx Holdings Employees
GoodRx Holdings had 697 employees as of December 31, 2025. The number of employees decreased by 41 or -5.56% compared to the previous year.
Employees
697
Change (1Y)
-41
Growth (1Y)
-5.56%
Revenue / Employee
$1,143,261
Profits / Employee
$43,671
Market Cap
784.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 697 | -41 | -5.56% | 697 | 0 |
| Dec 31, 2024 | 738 | 44 | 6.34% | 738 | 0 |
| Dec 31, 2023 | 694 | -260 | -27.25% | 694 | 0 |
| Dec 31, 2022 | 954 | 180 | 23.26% | 952 | 2 |
| Dec 31, 2021 | 774 | 301 | 63.64% | 756 | 18 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teladoc Health | 5,600 |
| TruBridge | 3,500 |
| Claritev | 3,000 |
| Phreesia | 1,789 |
| Certara | 1,576 |
| HealthStream | 1,160 |
| Omada Health | 916 |
| Weave Communications | 904 |
GDRX News
- 12 days ago - GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call - Business Wire
- 14 days ago - GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market - Benzinga
- 14 days ago - GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price - Business Wire
- 20 days ago - GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide - Business Wire
- 7 weeks ago - GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications - Business Wire
- 7 weeks ago - GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® - Business Wire
- 2 months ago - GoodRx Targets Digital Subscription Growth Amid 14% Dip in Active Consumers - PYMNTS
- 2 months ago - GoodRx Holdings Earnings Call Transcript: Q4 2025 - Transcripts